HeraMED (ASX:HMD) extended the closing date of its share and broker option offer made under its prospectus lodged with the Australian Securities and Investments Commission on Dec. 20, according to a Monday filing with the Australian bourse.
The extension follows the cancellation of the Australian Securities Exchange's Clearing House Electronic Subregister System batch settlement on Dec. 20, the filing said.
Shares of the company fell nearly 5% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.